Keyword: GSK

News

GlaxoSmithKine Investigates Alleged Bribery in Iraq

10.04.2014 - U.K. drugmaker GlaxoSmithKine (GSK), already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the company has confirmed. The latest...

News

GSK Combined Melanoma Treatment Delayed in Europe

28.03.2014 - GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the...

News

GlaxoSmithKline Offer lifts Indian Stakeholding to 75%

12.03.2014 - British drugmaker GlaxoSmithKline (GSK) said it has successfully increased its stake in its publicly-listed Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals...

News

Facing Fines, Glaxo SmithKline to Stop Drug Promotion Excesses

19.12.2013 - UK drugmaker Glaxo SmithKline has said it would cease offering financial incentives to doctors to promote its products through speaking engagements, for example. The company also...

News

Cameron Raises GSK’s Problems as CEO Joins Him On China Visit

03.12.2013 - British Prime Minister David Cameron raised GlaxoSmithKline's problems in China - where it is being investigated for alleged bribery - with political leaders on Monday as the...

News

Glaxo SmithKline to Invest in Scottish Plant expansion

27.11.2013 - Glaxo SmithKline (GSK) has announced plans to invest £25 million in expanding its active ingredient formulating plant at Montrose, Scotland. The UK drug maker said it would locate...

News

GSK Puts Lucozade and Ribena Drink Brands up for Sale

25.04.2013 - GlaxoSmithKline is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion pounds ($1.5 billion) and focus its consumer health business...

News

UK Watchdog Accuses GSK Over 'Pay-for-delay' Drug Deals

19.04.2013 - Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that paid them to delay launching cheap copies of its...